BLCO is Bausch + Lomb Corporation (Healthcare) — a non-dividend-paying stock. Trading at $18.00. Market cap: $6.43B. Capital Quality Rank: 50/100 — Stagnant mediocrity.
Stock snapshot
| Price | $18.00 |
| Market cap | $6.43B |
| Sector | Healthcare |
| Exchange | NYQ |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 50 / 100 · Stagnant mediocrity |
| ROIC (TTM) | 1.3% |
| Revenue CAGR (3y) | 10.6% |
| Shareholder buyback yield | -0.57% |
| Altman Z-score zone | Distress |
About BLCO
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Related non-dividend companies
Other non-dividend stocks investors research alongside BLCO. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is BLCO's current stock price?
BLCO (Bausch + Lomb Corporation) is currently trading at $18.00.
Does BLCO pay a dividend?
BLCO (Bausch + Lomb Corporation) does not currently pay a regular dividend.
What is BLCO's Capital Quality Rank?
BLCO has a Capital Quality Rank of 50/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track BLCO in DiviDrip
Add BLCO to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search BLCO and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.